Rye whole grain and bran intake compared with refined wheat decreases urinary C-peptide, plasma insulin, and prostate specific antigen in men with prostate cancer

Journal of Nutrition

Volumn 140, Issue 12, 2010, Pages 2180-2186

  Landberg, Rikard ^a   Andersson, Swen Olof ^b   Zhang, Jie Xian ^c   Johansson, Jan Erik ^b   Stenman, Ulf Håkan ^d   Adlercreutz, Herman ^e   Kamal Eldin, Afaf ^a   Åman, Per ^a   Hallmans, Göran ^c  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^c UMEÅ UNIVERSITY   (Sweden)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^e UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; C REACTIVE PROTEIN; CELLULOSE; GLUCOSE; INSULIN; PHYTOESTROGEN; PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; BLOOD SAMPLING; BRAN; CALORIC INTAKE; CANCER GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; EXCRETION; FOOD INTAKE; HUMAN; INFLAMMATION; INSULIN BLOOD LEVEL; MALE; PROSTATE CANCER; PROTEIN URINE LEVEL; RYE; URINALYSIS; WHEAT;

C-PEPTIDE; DIETARY FIBER; HUMANS; INSULIN; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SECALE CEREALE; TRITICUM;

ANIMALIA; SECALE CEREALE; TRITICUM AESTIVUM;

EID: 78649558237     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.110.127688     Document Type: Article

References (54)

1. Suzuki R, Allen NE, Key TJ, Appleby PN, Tjønneland A, Johnsen NF, Jensen MK, Overvad K, Boeing H, et al. A prospective analysis of the association between dietary fiber intake and prostate cancer risk in EPIC. Int J Cancer. 2009;124:245-9.
2. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K. Environmental and heritable factors in the causation of cancer: analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000;343:78-85.
3. Chan JM, Gann PH, Giovannucci EL. Role of diet in prostate cancer development and progression. J Clin Oncol. 2005;23:8152-60.
4. Hedelin M, Augustsson-Bälter K, Chang ET, Bellocco R, Klint Å, Johansson J-E, Wiklund F, Thellenberg-Karlsson C, Adami H-O, et al. Dietary intake of phytoestrogens, estrogen receptor-beta polymorphisms and the risk of prostate cancer. Prostate. 2006;66:1512-20.
5. Heinonen OP, Albanes D, Virtamo J, Taylor PR, Huttunen JK, Hartman AM, Haapakoski J, Malila N, Rautalahti M, et al. Prostate cancer and supplementation with alpha-tocopherol and beta- carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst. 1998;90:440-6.
6. Lippman SM, Goodman PJ, Klein EA, Parnes HL, Thompson IM, Kristal AR, Santella RM, Probstfield JL, Moinpour CM, et al. Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). J Natl Cancer Inst. 2005;97:94-102.
7. Li Z, Aronson WJ, Arteaga JR, Hong K, Thames G, Henning SM, Liu W, Elashoff R, Ashley JM, Herber D. Feasibility of a low-fat/high-fiber diet intervention with soy supplementation in prostate cancer patients after prostatectomy. Eur J Clin Nutr. 2008;62:526-36.
8. Carmody J, Olendzki B, Reed G, Andersen V, Rosenzweig P. A dietary intervention for recurrent prostate cancer after definitive primary treatment: results of a randomized pilot trial. Urology. 2008;72:1324-8.
9. Demark-Wahnefried W, Price DT, Polascik TJ, Robertson CN, Anderson EE, Paulson DF, Walther PJ, Gannon M, Vollmer RT. Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features. Urology. 2001;58:47-52.
10. Ornish D, Weidner G, Fair WR, Marlin R, Pettengill EB, Raisin CJ, Dunn-Emke S, Crutchfield L, Jacobs FN, et al. Intensive lifestyle changes may affect the progression of prostate cancer. J Urol. 2005;174:1065-70.
11. Tariq N, Jenkins DJA, Vidgen E, Fleshner N, Kendall CWC, Story JA, Singer W, D'Costa M, Struthers N. Effect of soluble and insoluble fiber diets on serum prostate specific antigen in men. J Urol. 2000;163:114-8.
12. Barnard RJ. Prostate cancer prevention by nutritional means to alleviate metabolic syndrome. Am J Clin Nutr. 2007;86:S889-93.
13. Hammarsten J, Högstedt B. Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancer. Eur J Cancer. 2005;41:2887-95.
14. Ma J, Li H, Giovannucci E, Mucci L, Qiu W, Nguyen PL, Gaziano JM, Pollak M, Stampfer MJ. Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis. Lancet Oncol. 2008;9:1039-47.
15. Fardet A. New hypotheses for the health-protective mechanisms of whole-grain cereals: what is beyond fibre? Nutr Res Rev. 2010;23:65-134.
16. Mellen PB, Walsh TF, Herrington DM. Whole grain intake and cardiovascular disease: a meta-analysis. Nutr Metab Cardiovasc Dis. 2008;18:283-90.
17. de Munter JS, Hu FB, Spiegelman D, Franz M, van Dam RM. Whole grain, bran and germ intake and risk of type 2 diabetes: a prospective cohort study and systematic review. PLoS Med. 2007;4:261.
18. Kasum CM, Nicodemus K, Harnack LJ, Jacobs DR Jr, Folsom AR. Whole grain intake and incident endometrial cancer: the Iowa Women's Health Study. Nutr Cancer. 2001;39:180-6.
19. Larsson SC, Giovannucci E, Bergkvist L, Wolk A. Whole grain consumption and risk of colorectal cancer: a population-based cohort of 60,000 women. Br J Cancer. 2005;92:1803-7.
20. World Cancer Research Fund. Food, nutrition, physical activity and the prevention of cancer: a global perspective. Washington, DC: AICR; 2007.
21. Bylund A, Lundin E, Zhang J-X, Nordin A, Kaaks R, Stenman U-H, Åman P, Adlercreutz H, Nilsson T, et al. Randomized controlled short-term intervention pilot study on rye bran bread in prostate cancer. Eur J Cancer Prev. 2003;12:407-15.
22. Bylund A, Zhang JX, Bergh A, Damber JE, Widmark A, Johansson A, Adlercreutz H, Åman P, Shepherd MJ, et al. Rye bran and soy protein delay growth and increase apoptosis of human LNCaP prostate adenocarcinoma in nude mice. Prostate. 2000;42:304-14.
23. Landström M, Zhang JX, Hallmans G, Åman P, Bergh A, Damber JE, Mazur W, WähäläK, Adlercreutz H. Inhibitory effects of soy and rye diets on the development of Dunning R3327 prostate adenocarcinoma in rats. Prostate. 1998;36:151-61.
24. Polascik TJ, Oesterling JE, Partin AW. Prostate specific antigen: a decade of discovery-what we have learned and where we are going. J Urol. 1999;162:293-306.
25. Aronson WJ, Bernard RJ, Freeland SJ, Henning S, Elashoff D, Jardack PM, Cohen P, Heber D, Kobayashi N. Growth inhibitory effect of low fat diet on prostate cancer cells: results of a prospective, randomized dietary intervention trail in men with prostate cancer. J Urol. 2010;183:345-50.
26. Landberg R, Kamal-Eldin A, Andersson S-O, Johansson J-E, Zhang J-X, Hallmans G, Aman P. Reproducibility of plasma alkylresorcinols during a 6-week rye intervention study in men with prostate cancer. J Nutr. 2009;139:975-80.
27. Mitrunen K, Pettersson K, Piironen T, Björk T, Lilja H, Lövgren T. Dual-label one-step immunoassay for simultaneous measurement of free and total prostate-specific antigen concentrations and ratios in serum. Clin Chem. 1995;41:1115-20.
28. Landberg R, Åman P, Kamal-Eldin A. A rapid GC-MS method for quantification of alkylresorcinols in human plasma. Anal Biochem. 2009;385:7-12.
29. Penalvo JL, Haajanen KM, Botting N, Adlercreutz H. Quantification of lignans in food using isotope dilution gas chromatography/mass spectrometry. J Agric Food Chem. 2005;53:9342-7.
30. Nurmi T, Voutilainen S, Nyyssönen K, Adlercreutz H, Salonen JT. Liquid chromatography method for plant and mammalian lignans in human urine. J Chromatogr B Analyt Technol Biomed Life Sci. 2003;798:101-10.
31. Peñalvo JL, Nurmi T, Haajanen K, Al-Maharik N, Botting N, Adlercreutz H. Determination of lignans in human plasma by liquid chromatography with coulometric electrode array detection. Anal Biochem. 2004;332:384-93.
32. Kamal-Eldin A, Frank J, Razdan A, Tengblad S, Basu S, Vessby B. Effects of dietary phenolic compounds on tocopherol, cholesterol and fatty acids in rats. Lipids. 2000;35:427-35.
33. Koppie TM, Grossfeld GD, Miller D, Yu J, Stier D, Broering JM, Lubeck D, Henning JM, Flanders SC, et al. Patterns of treatment of patients with prostate cancer initially managed with surveillance: results from the Capsure database. J Urol. 2000;164:81-8.
34. Lundin EA, Zhang JX, Lairon D, Tidehag P, Åman P, Adlercreutz H, Hallmans G. Effects of meal frequency and high-fibre rye-bread diet on glucose and lipid metabolism and ileal excretion of energy and sterols in ileostomy subjects. Eur J Clin Nutr. 2004;58:1410-9.
35. Laaksonen DE, Toppinen LK, Juntunen KS, Autio K, Liukkonen K-H, Poutanen KS, Niskanen L, Mykkanen HM. Dietary carbohydrate modification enhances insulin secretion in persons with the metabolic syndrome. Am J Clin Nutr. 2005;82:1218-27.
36. Leinonen K, Liukkonene K, Poutanen K, Uusitupa M, Mykkanen HM. Rye bread decreases postprandial insulin response but does not alter glucose response in healthy Finnish subjects. Eur J Clin Nutr. 1999;53:262-7.
37. Werner H, Bruchim I. The insulin-like growth factor-I receptor as an oncogene. Arch Physiol Biochem. 2009;115:58-71.
38. Kojima S, Inahara M, Suzuki H, Ichikawa T, Furuya Y. Implications of insulin-like growth factor-I for prostate cancer therapies. Int J Urol. 2009;16:161-7.
39. Katcher HI, Legro RS, Kunselman AR, Gillies PJ, Demers LM, Bagshaw DM, Kris-Etherton PM. The effects of a whole grain enriched hypocaloric diet on cardiovascular disease risk factors in men and women with metabolic syndrome. Am J Clin Nutr. 2008;87:79-90.
40. Kallio P, Kolehmainen M, Laaksonen DE, Kekalainen J, Salopuro T, Sivenius K, Pulkkinen L, Mykkanen HM, Niskanen L, et al. Dietary carbohydrate modification induces alterations in gene expression in abdominal subcutaneous adipose tissue in persons with the metabolic syndrome: the FUNGENUT Study. Am J Clin Nutr. 2007;85:1417-27.
41. De Marzo AM, Platz EA, Sutcliffe S, Xu J, Gronberg H, Drake CG, Nakai Y, Isaacs WB, Nelson WG. Inflammation in prostate carcinogenesis. Nat Rev Cancer. 2007;7:256-69.
42. Sun J, Hedelin M, Zheng SL, Adami H-O, Bensen J, Augustsson-Bälter K, Chang B, Adolfsson J, Adams T, et al. Interleukin-6 sequence variants are not associated with prostate cancer risk. Cancer Epidemiol Biomarkers Prev. 2004;13:1677-9.
43. Pierce B, Biggs M, DeCambre M, Reiner A, Li C, Fitzpatrick A, Carlson C, Stanford J, Austin M. C-reactive protein, interleukin-6, and prostate cancer risk in men aged 65 years and older. Cancer Causes control. 2009;20:1193-203.
44. Hsieh LJ, Carter HB, Landis PK, Tucker KL, Metter EJ, Newschaffer CJ, Platz EA. Association of energy intake with prostate cancer in a long-term aging study: Baltimore longitudinal study of aging (United States). Urology. 2003;61:297-301.
45. Zhang JX, Lundin E, Hallmans G, Adlercreutz H, Andersson H, Bosaeus I, Aman P, Stenling R, Dahlgren S. Effect of rye bran on excretion of bile acids, cholesterol, nitrogen, and fat in human subjects with ileostomies. Am J Clin Nutr. 1994;59:389-94.
46. Le Gall M, Serena A, Jørgensen H, Theil PK, Bach Knudsen KE. The role of whole-wheat grain and wheat and rye ingredients on the digestion and fermentation processes in the gut? A model experiment with pigs. Br J Nutr. 2009;102:1590-600.
47. Bach Knudsen KE, Serena A, Kjaer AKB, Jorgensen H, Engberg R. Rye bread enhances the production and plasma concentration of butyrate but not the plasma concentrations of glucose and insulin in pigs. J Nutr. 2005;135:1696-704.
48. Lele RD. Pro-insulin, C peptide, glucagon, adiponectin, TNFa, AMPK: neglected players in type 2 diabetes mellitus. J Assoc Physicians India. 2010;58:30-6.
49. Hu G-X, Chen G-R, Xu H, Ge R-S, Lin J. Activation of the AMP activated protein kinase by short-chain fatty acids is the main mechanism underlying the beneficial effect of a high fiber diet on the metabolic syndrome. Med Hypotheses. 2010;74:123-6.
50. Venkateswaran V, Haddad AQ, Fleshner NE, Fan R, Sugar LM, Nam R, Klotz LH, Pollak M. Association of diet-induced hyperinsulinemia with accelerated growth of prostate cancer (LNCaP) xenografts. J Natl Cancer Inst. 2007;99:1793-800.
51. Adlercreutz H. Lignans and human health. Crit Rev Clin Lab Sci. 2007;44:483-525.
52. Nurmi T, Mursu J, Peñalvo JL, Poulsen HE, Voutilainen S. Dietary intake and urinary excretion of lignans in Finnish men. Br J Nutr. 2010;103:677-85.
53. Adlercreutz H, Mousavi Y, Clark J, Höckerstedt K, Hämäläinen E, Wähälä K, Mäkelä T, Hase T. Dietary phytoestrogens and cancer: in vitro and in vivo studies. J Steroid Biochem Mol Biol. 1992;41:331-7.
54. Sonn GA, Aronson W, Litwin MS. Impact of diet on prostate cancer: a review. Prostate Cancer Prostatic Dis. 2005;8:304-10.